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aldosterone Disrupts the intercellular 
Flow of glucose in cardiac Muscle
Walmor C. De Mello*
School of Medicine, University of Puerto Rico, San Juan, PR, USA
The activation of the renin–angiotensin system is known to impair intercellular commu-
nication in the heart, but the role of aldosterone on the process of chemical communi-
cation and particularly the intercellular diffusion of glucose between cardiomyocytes is 
not known. This problem was investigated in cell pairs isolated from the left ventricle of 
adult Wistar Kyoto rats. For this, fluorescent glucose was dialyzed into one cell of the 
pair using the whole cell clamp technique, and its diffusion from cell-to-cell through gap 
junctions was followed by measuring the fluorescence intensity in the dialyzed as well 
as in non-dialyzed cell as a function of time. The results indicated that (1) in cell pairs 
exposed to aldosterone (100 nM) for 24 h, the intercellular flow of glucose through gap 
junctions was disrupted; (2) although the mechanism by which aldosterone disrupts 
the cell-to-cell flow of glucose is multifactorial, two major factors are involved: oxidative 
stress and PKC activation; (3) the effect of aldosterone was significantly reduced by 
spironolactone (100 nM); and (4) calculation of gap junction permeability (Pj) indicated 
an average values of 0.3 ± 0.001 × 10−4 cm/s (n = 31) (four animals) for controls and 
24 ±  0.03 ×  10−6  cm/s (n =  34) (four animals) (P <  0.05) for cell pairs exposed to 
aldosterone (100 nM) for 24 h. Bis-1 (10−9M), which is a selective PKC inhibitor, added to 
the aldosterone solution, improved the value of Pj to 0.21 ± 0.001 × 10−4 cm/s (n = 24) 
(P < 0.05), whereas spironolactone (100 nM) added to aldosterone solution, reduced 
significantly the effect of the hormone on junctional permeability to glucose.
Keywords: aldosterone, gap junction permeability, glucose heart
highlighTs
• Aldosterone inhibits the cell-to-cell diffusion of glucose in heart.
• Spironolactone inhibits the effect of aldosterone.
• The gap junction permeability is drastically reduced by aldosterone.
• Oxidative stress is involved in the effect of aldosterone.
inTrODUcTiOn
Aldosterone is normally involved in the regulation of blood volume and blood pressure. In the 
last decades, evidence has been provided that the hormone has many effects independently of its 
regulatory role on blood volume. Aldosterone, for instance, binds to the mineralocorticoid receptor 
(MR), which resides predominantly in the cytoplasm. Upon ligand binding, the MR acts as a tran-
scription factor generating cardiac remodeling, including hypertrophy and fibrosis (1–5), especially 
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during heart failure  –  an effect blocked by spironolactone (6). 
Moreover, the hormone enhances the expression of Ang II AT1 
receptors in ventricular muscle by twofold (3), an effect inhibited 
by eplerenone (4), and it is involved in a proliferative response 
through increased expression of p53-bing protein (7). During 
pathological conditions, such as myocardial infarction, the pro-
duction of aldosterone in the cardiac muscle is enhanced, (5) and 
the cardiac levels of Ang II are increased (7). Both aldosterone and 
Ang II are involved in the increase of collagen deposition during 
myocardial infarction [see Ref. (8)], creating a severe impairment 
of ventricular relaxation and impulse propagation with genera-
tion of cardiac arrhythmias. Transcription effects of aldosterone 
take more than 3  h, whereas rapid non-genomic effects of the 
hormone can occurs within minutes. Signaling pathways related 
to the rapid MR/aldosterone responses include the MAPK family 
and protein kinase C (PKC) (9) as well as intracellular levels of 
calcium, cAMP, and nitric oxide (10, 11).
Clinical trials involving patients with heart failure revealed 
that MR antagonists reduces morbidity and mortality (6) even 
when the circulating levels of aldosterone are within normal 
range, highly suggesting that the activation of local renin–angio-
tensin aldosterone system (RAAS) is an important contributor 
factor during heart failure. Other clinical studies showed that 
elevated plasma aldosterone levels facilitate the development of 
insulin resistance by increasing oxidative stress and by changing 
insulin signaling with consequent decrease of glucose transport. 
Furthermore, enhanced aldosterone levels are associated with 
myocardial infarction and stroke (12).
Cardiac cells are communicated through gap junction channels 
which are composed of two oligomers and each oligomer is a con-
nexon which contains connexins (13). Connexin43 (Cx43) is the 
main connexin present in cardiac muscle. Connexins contain four 
transmembrane domains with the amino and carboxyl termini 
on the cytoplasmic side. The intercellular channels make possible 
the spread of ions and electrical current from cell-to-cell, which 
is essential for the electrical synchronization in the heart (14), 
and is also involved in the intercellular diffusion of amino acids, 
nucleotides, hormones, and other small molecules up to 1 kDa 
contributing to the metabolic cooperation between cells (15, 16). 
Aldosterone reduces the expression of connexin43 (Cx43), which 
is the main connexin in cardiac muscle (17). Recently, it was 
found that glucose flows from cell-to-cell through gap junctions 
in cardiac muscle (16), which indicates that cardiomyocytes share 
this energy substrate and cooperate metabolically (16, 18). No 
information is available if aldosterone influences the intercellular 
diffusion of glucose. These observations might have important 
implications for heart failure, hypertension, and diabetes when 
the RAAS is activated. In this work, this problem was investigated 
in ventricular myocytes isolated from adult Wistar Kyoto rats.
MaTerials anD MeThODs
Normal adult Wistar Kyoto rats were used. The animals were kept 
in the Animal House at constant temperature (24°C) and humid-
ity following the recommendations of NIH. Animals were kept on 
a normal laboratory animal diet and given tap water ad libitum. 
The animals were anesthetized with 43 mg/kg of ketamine plus 
5 mg/kg of xylazine, and the heart was removed with the animals 
under deep anesthesia. All animal procedures were approved by 
the IACUC.
cell isolation Procedure
The heart was removed and immediately perfused with 
normal Krebs solution containing (millimolar): NaCl – 136.5; 
KCl  –  5.4; CaCl2  –  1.8; MgCl2  –  0.53; NaH2PO4  –  0.3; 
NaHCO3 – 11.9; glucose – 5.5; HEPES – 5, pH adjusted to 7.3. 
After 20 min, a Ca-free solution containing 0.4% collagenase 
(Worthington Biochemical Corp.) was recirculated through 
the heart for 1  h. The collagenase solution was washed out 
with 100  ml of recovery solution containing (millimolar): 
taurine 10, oxalic acid 10, glutamic acid 70, KCl 25, KH2PO4 
10, glucose 10, and EGTA 0.5; pH 7.4. All solutions were oxy-
genated with 100% O2. Ventricles were minced (1–2 mm thick 
slices) and the resulting solution was agitated gently and the 
suspension was filtered. The filtrate was centrifuged for 4 min 
at 22 × g. The cell pellets were then resuspended in normal 
Krebs solution.
experimental Procedures
All experiments were performed in a small chamber mounted 
on the stage of an inverted phase-contrast microscope (Diaphot, 
Nikon). Ventricular cells were placed in a modified cultured 
dish (volume 0.75  ml) in an open-perfusion microincubator 
(Model PDMI-2, Medical Systems). Cells were allowed to adhere 
to the bottom of the chamber for 15 min and were superfused 
with normal Krebs solution (3 ml/min) that permits a complete 
change of the bath in <500 ms. A video system made possible to 
inspect the cells and the pipettes throughout the experiments. The 
electrical measurements were carried out using the patch clamp 
technique in a whole cell configuration using an Axon (model 
200B) patch-clamp amplifier and Digidata 1400 (Molecular 
Devices, CA, USA).
Measurements of intercellular Diffusion of 
glucose
Cell pairs of ventricular myocytes were used. Suction pipettes were 
pulled from microhematocrit tubing by means of a controlled 
puller (Narashige, Japan) and filled with a solution with the fol-
lowing composition (millimolar): cesium aspartate 120, NaCl 10, 
MgCl2 3, EGTA 10, tetraethylammonium chloride 20, Na2ATP 5, 
and HEPES 5; pH 7.3. In some experiments, fluorescent glucose 
(molecular weight 180 Da) (4%) was added to the pipettes. The 
pipette was attached to one cell of the pair, a gigaohm seal was 
achieved and then the membrane was ruptured by a brief suction 
allowing the fluorescent glucose to diffuse from the pipette into 
the cell.
Measurements of cell Width
Measurements of cell width – a major component of cardiac cell 
volume variation – were made in quiescent ventricular myocytes 
incubated for 24  h with Krebs solution containing aldosterone 
(100 nM), an inverted phase-contrast microscope (Nikon), and 
a high-resolution camera (Paxcam). Cell width was measured 
FigUre 2 | inhibition of cell-to-cell diffusion of fluorescent glucose in 
cell pairs exposed to aldosterone (100 nM) for 24 h. Each point is the 
average from 25 cell pairs (four animals) isolated from the left ventricle. 
Vertical line at each point SEM (P < 0.05).
FigUre 1 | Top – absence of intercellular diffusion of fluorescent 
glucose in single cell pair exposed to aldosterone (100 nM) for 24 h. 
Arrow indicates site of micropipette filled with glucose.
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using Image J software (150 randomly chosen cells/well, NIH, 
Bethesda, MD, USA).
Measurements of Oxidative stress
To directly monitor real-time reactive oxygen/nitrogen spe-
cies (ROS/RNS), a kit including an oxidative stress detection 
reagent (ENZO Life Sciences, Farmingdale, NY, USA) was used. 
Measurements of fluorescence intensity were made in controls 
and in cells exposed to aldosterone (100  nM) for 24  h. The 
oxygen/nitrogen species kit was added for 30 min and the green 
fluorescence was measured again using a wide filed fluorescence 
microscope equipped with standard green (490/525 nm) filter set.
influence of PKc inhibition
The influence of PKC activation on the effect of aldosterone was 
investigated. For this, cell pairs were exposed to aldosterone 
(100  nM) plus Bis-1 (10−9M), which is a selective inhibitor of 
PKC. After 24 h, fluorescent glucose was dialyzed into cell pairs as 
described above and cell-to-cell diffusion of glucose was followed 
as a function of time.
Drugs
Aldosterone and spironolactone were from Sigma Chemical Co., 
Saint Louis, MO, USA. Bis-1 was from Calbiochem.
statistical analysis
Data are expressed as mean ±  SEM. Student’s t-test was used. 
Differences were considered significant when P < 0.05.
resUlTs
aldosterone Disrupts intercellular Flow of 
glucose
Previous observations indicated that in the normal heart, glucose 
flows from cell-to-cell through gap junctions (16). To investigate 
the influence of aldosterone on the intercellular diffusion of glu-
cose, cell pairs isolated from the left ventricle of normal Wistar 
Kyoto rats were used. Fluorescent glucose was dialyzed into one 
cell of the pair and its diffusion through the gap junction was 
followed by measuring the fluorescence intensity in both cells of 
the pair as a function of time. As shown in Figures 1 and 2, in cell 
pairs exposed to aldosterone (100 nM) for 24 h, the intercellular 
movement of glucose was drastically reduced. Exposure of the 
cell pairs to aldosterone (100 nM) for 15 min did not change the 
junctional permeability to glucose (not shown).
To investigate the role of the MRs on the effect of aldosterone, 
cell pairs were exposed to aldosterone (100 nM) plus spironolac-
tone (100 nM) for a period of 24 h. Measurements of intercellular 
diffusion of glucose performed at the end of this time indicated 
that spironolactone reduces the effect of aldosterone on the 
intercellular flow of glucose as shown in Figure 3.
effect of aldosterone on cell Width
Because cell swelling is known to cause a decline of gap junction 
permeability (19), it is important to investigate if the hormone 
changes the cell volume of cardiac cells. To investigate this possi-
bility, measurements of cell width were performed in absence and 
after 24 h of exposure to aldosterone (100 nM). Figure 4 shows 
that aldosterone increases the cell width significantly, while 
spironolactone (100 nM) added to aldosterone solution reduced 
significantly the effect of the hormone on cell width.
role of Oxidative stress
Oxidative stress induced by the activation of MR is known to 
cause diastolic dysfunction and ventricular hypertrophy in rats 
(20). To investigate the possible role of oxidative stress on the 
decoupling action of aldosterone, isolated cells were incubated 
with Krebs solution containing aldosterone (100 nM) for 24 h and 
then exposed to the oxidative stress detection reagent for 30 min. 
Measurements revealed that the green fluorescence intensity 
inside the cells was significantly increased in cells incubated with 
aldosterone when compared with controls (see Figures 5 and 6).
In some experiments, measurements of reactive species were 
performed in presence of an inhibitor of ROS/RNS (ENZO Life 
Sciences). The results revealed a significant decline of green 
fluorescence elicited by aldosterone (100 nM). Moreover, meas-
urements of gap junction permeability to glucose performed 
FigUre 5 | influence of aldosterone on oxidative stress. (a) Control 
fluorescence microscopy of single cell under control conditions, left bottom; 
(B) green fluorescence measured in the same cell after administration of 
aldosterone (100 nM).
FigUre 4 | increase of cell width elicited by aldosterone (100 nM) and 
the effect of spironolactone (100 nM) on cell swelling induced by 
aldosterone. Each bar is the average from 20 cells. Vertical line at each bar 
SEM (P < 0.05).
FigUre 3 | spironolactone (100 nM) added to aldosterone (100 nM) 
solution reduced the effect of aldosterone on the intercellular flow of 
glucose. Each point is the average from 26 cell pairs. Vertical line at each 
point SEM (P < 0.05).
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under these conditions indicated larger values of junctional 
permeability, Pj = 0.1 ± 0.002 × 10−4 cm/s (n = 12) (P < 0.05).
role of PKc inhibition
Previous findings revealed that activation of PKC and consequent 
phosphorylation of connexin 43 decreases the dye coupling 
between cells increasing the preponderance of lower values of 
single channel conductance and permeability (21, 22). These 
observations led us to investigate if aldosterone reduces the gap 
junction permeability to glucose by activating PKC. For this, Bis-
1, which is an inhibitor of PKC (10−9M), was added to aldosterone 
solution and after 24 h fluorescent glucose was dialyzed into the 
cell, and its intercellular diffusion was followed as a function of 
time. The results from several experiments indicated that the 
PKC inhibitor reduces drastically the effect of aldosterone on 
junctional permability (see Figure 7).
Quantitative Measurements of gap 
Junction Permeability
A quantitative estimation of the gap junction permeability to 
glucose (Pj) was made using the following equation (23):
 Pj Vcell Aj Kj= ×/  
where Vcell is the cell volume that is accessible to glucose, 
Aj is area of the gap junctional membrane, and Kj is the rate 
constant of the transjunctional diffusion (23). Morphometric 
studies performed on ventricular tissues (24) indicate that 
Aj contributes to 17% of the cross sectional area of the rat 
cardiomyocyte (177  mm2) and the myofibrils, mitochondria, 
sarcoplasmic reticulum, and nucleus occupies about 88% of 
the total cell volume leaving 12% of total cell volume free for 
the diffusion of glucose through the cytoplasm. The junctional 
permeability to glucose (Pj) was then calculated for controls 
and for cell pairs exposed to aldosterone (100 nM) or to aldos-
terone (100  nM) plus spironolactone (100  nM) for 24  h. As 
shown in Table 1, Pj calculated for the controls taken Vcell as 
12% of total cell volume was equal to 0.3 ± 0.001 × 10−4 cm/s 
(n = 31) (four animals). An appreciable decrease of junctional 
permeability was found in cell pairs exposed to aldosterone 
(100  nM) [24 ±  0.03  ×  10−6  cm/s (n =  34) (four animals) 
TaBle 1 | influence of aldosterone alone and aldosterone (100 nM) plus 
spironolactone (100 nM) on the gap junction permeability (Pj) (cm/s) to 
glucose.
control aldosterone aldosterone plus 
spironolactone
0.3 ± 0.001 × 10−4 
(n = 31) (4 animals)
24 ± 0.003 × 10−6 
(n = 34) (4 animals)
2.4 ± 0.004 × 10−5 
(n = 29) (4 animals)
P < 0.05 P < 0.05
Cells were exposed to aldosterone or aldosterone plus spironolactone for 24 h.
FigUre 7 | influence of PKc inhibition on the effect of aldosterone on 
junctional permability to glucose. Cell pairs were exposed to aldosterone 
(100 nM) plus Bis-1 (10−9M) for 24 h and cell-to-cell diffusion of glucose was 
investigated. Each point is the average from 23 cell pairs (3 animals). Vertical 
line at each point SEM (P < 0.05).
FigUre 6 | influence of aldosterone on oxidative stress. Each bar is the average from 23 ventricular myocytes (4 animals). Vertical line at each bar SEM 
(P < 0.05).
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(P < 0.05)] taking 12% of the total volume, which was assumed 
60% larger than the controls due to cell swelling (see Table 1). 
In cell pairs exposed to aldosterone plus spironolactone 
(100  nM), the value of Pj was significantly greater than that 
achieved with aldosterone alone (see Table  1). The value of 
junctional permeability (Pj) in presence of Bis-1 (10−9M) and 
aldosterone (100 nM) was 0.21 ± 0.0011 × 10−4 cm/s (n = 24) 
(P < 0.05).
DiscUssiOn
The present results indicated, for the first time, that aldoster-
one disrupts chemical communication and the intercellular 
diffusion of glucose in the normal heart  –  an effect related 
to the activation of the MR. Since Ang II is known to release 
aldosterone by the adrenal gland, it is possible to conclude 
that the activation of the RAAS is involved in the regulation 
of intercellular diffusion of glucose in the heart. The mecha-
nism by which the MR activation disrupts the cell-to-cell 
diffusion of glucose seems complex and multifactorial (see 
Figure 5) mainly involving the generation of oxidative stress, 
the downregulation of connexin43 (Cx43) (17), which is the 
main connexin in the heart and PKC activation. Aldosterone 
might contribute to the deterioration of chemical coupling 
by activation ERK, JNK, and p38 MAPKs (25). On the other 
hand, the effect of the hormone on the intracellular ion regula-
tion (26) cannot be discarded. It is known, for instance, that 
aldosterone, rapidly increases [Na+]i and cell volume via Na+ 
K+ 2Cl− cotransporter (NKCCl) and Na+/H+ exchange (NHE) 
(26). An increment of cell width was indeed, found in cells 
exposed to aldosterone for 24 h (see above). Since cell swelling 
decreases the gap junction permeability (19), it is conceivable 
FigUre 8 | Diagram illustrating the influence of aldosterone on the junctional permeability (Pj) to glucose through the generation of oxidative stress 
an activation of PKc.
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that the cell swelling induced by aldosterone contributes to 
the disruption of cell-to-cell diffusion of glucose as described 
above.
Concerning the possible effect of aldosterone on the expression 
of Cx43, previous observations revealed that the downregulation 
of Cx43 expression elicited by aldosterone was not suppressed 
by eplerenone (17). Other studies indicated that spironolactone 
reverses gap junction remodeling during ventricular hypertrophy 
(27). Since spirinolactone decreased significantly the effect of 
aldosterone on the intercellular flow of glucose, the contribution 
of a decline in Cx43 remodeling to the disruption of intercellular 
movement of glucose cannot be ruled out.
It is known that phosphorylation of gap junction proteins 
including connexin43, which is the main connexin in cardiac 
muscle, leads to a decrease of gap junction permeability and con-
ductance (21, 22). On the other hand, evidence is available that 
aldosterone induces cellular effects through activation of PKC 
[see Ref. (28)] and that PKC activation may result from oxidative 
stress or lead to ROS generation. Indeed, PKC-dependent phos-
phorylation of Ser368 in Cx43 decreases intercellular coupling 
due to altered junctional permeability (29). These findings might 
indicate that the decline of intercellular flow of glucose caused by 
aldosterone is related to oxidative stress-induced PKC activation 
as shown in Figures 7 and 8.
Although it is well established that aldosterone produces 
MR-mediated injury, the hormone mediates part of Ang 
II-induced cardiac injury and gene expression suggesting a 
cross-talk between the hormone and the peptide. Previous stud-
ies showed that high glucose impairs the intercellular flow of 
glucose due, in part, due to the increased Ang II levels inside the 
cells (16, 18). Moreover, the enhanced synthesis of aldosterone 
during myocardial infarction is mediated by Ang II AT1 receptors 
(3, 30), and beta arrestin generated locally plays a role in Ang 
II-mediated aldosterone production (31). It is then reasonable 
to think that Ang II generated by the activation of the RAS can 
contribute to the decoupling action of aldosterone as described 
above by activating PKC and inducing oxidative stress.
It is known that not only aldosterone but also cortisol can 
cause cell death during MI (32, 33) indicating an important role 
of glucorticoids. Since no studies were included on the influence 
of cortisol on the intercellular diffusion of glucose, further obser-
vations will be needed to clarify this point.
Previous observations showed that mitochondria oxidative 
stress contributes to Ang II-induced gap junction remodeling 
(34) and that mitochondria can generate aldosterone (35). These 
findings might indicate that the mitochondria oxidative stress 
participates in the deterioration of chemical communication 
between heart cells. It is known that aldosterone, for instance, 
causes intramitochondrial Ca2+ overloading and oxidative stress 
with opening of the mitochondrial permeability transition pore 
(36). Although mitochondrial ROS has an important role in 
normal physiological cell signaling, overproduction of mitochon-
drial ROS elicited by high glucose as well as Ang II and hypoxia, 
lead to cardiovascular damage. Therefore, the possible role of 
mitochondrial ROS on the inhibition of intercellular glucose 
diffusion elicited by aldosterone cannot be discarded.
The interruption of intercellular transfer of glucose elicited by 
aldosterone has important consequences for tissue homeostasis 
and ATP synthesis. A reduction of the Na pump, for instance, 
results in an increment of the intracellular sodium concentration 
and membrane depolarization with consequent change of cardiac 
excitability. It is known that aldosterone generates triggered 
activity caused by early-afterdepolarization (EAD) and delayed 
afterdepolarization (DAD), which is associated with intracellular 
Ca2+ mishandling (37). Transgenic mice with cardiac-specific 
MR overexpression show prolonged ventricular repolarization 
and severe arrhythmia associated with a decrease of outward 
potassium current (38) and abnormal Ca2+ release from the 
sarcoplasmic reticulum during diastole with consequent genera-
tion of cardiac arrhythmias (37). Since an increase of intracellular 
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calcium concentration is known to impair heart cell communica-
tion (14), one cannot rule out the possibility that the increment 
of intracellular Ca2+ contributes to the decrease of junctional 
permeability to glucose as described above.
The disruption of cell-to-cell diffusion of glucose elicited by 
aldosterone generates discrepant intracellular levels of glucose 
with consequent variation of ATP synthesis resulting in different 
energy levels with serious consequences for cellular function. The 
interruption of intercellular flow of glucose might be particularly 
harmful for the failing or diabetic heart in which the cardiac cell 
energy is already reduced and the transport of glucose through 
the surface cell membrane is impaired. The physiological conse-
quences of interruption of intercellular diffusion of glucose in the 
heart are not known and require further studies.
limitations of the Present studies
 (1) Although the present measurements of oxidative stress indi-
cated its contribution to the effect of aldosterone on the inter-
cellular diffusion of glucose, further studies using stronger 
inhibitors of oxidative stress will be needed to confirm the 
present findings.
 (2) The physiological consequences of the disruption of glucose 
transport through gap junction are not known. A pos-
sible result of this disruption is the generation of different 
intracellular levels of glucose throughout the ventricle leading 
to unequal intracellular ATP levels with all the consequences 
for cellular energetics. Certainly, further studies will be 
needed to clarify these points.
 (3) Although previous studies revealed that aldosterone reduces 
the expression of Cx43 in cardiac cells of neonatal rats, similar 
studies will be necessary to confirm the effect of the hormone 
in adult-differentiated cardiomyocytes.
cOnclUsiOn
Aldosterone disrupts the exchange of glucose between cardiac cells 
by reducing the gap junction permeability. The mechanism by which 
aldosterone changes the gap junction permeability is not known but 
it is probably multifactorial, including changes in cell volume, oxida-
tive stress, and phosphorylation of gap junction proteins. Moreover, 
a down regulation of Cx43 (17) might contribute to the disruption 
of intercellular flow of glucose between the cardiomyocytes, but 
further studies will be needed to confirm this possibility.
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